SCHEMBL9733475

SCHEMBL9733475

CC(C)(CC(=O)c1ccc(O)cc1)C(=O)O

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD17B3 P37058 8/20 0.52
PTPN1 P18031 1/20 0.50
NPC1 O15118 1/20 0.50
RAB9A P51151 1/20 0.50
BLM P54132 2/20 0.48
KDM4E B2RXH2 1/20 0.48
ALDH1A1 P00352 1/20 0.48
ABL1 P00519 1/20 0.48
POLB P06746 1/20 0.48
ALPI P09923 1/20 0.48
GAA P10253 1/20 0.48
ALPG P10696 1/20 0.48
APEX1 P27695 1/20 0.48
CASP3 P42574 1/20 0.48
RECQL P46063 1/20 0.48
CASP7 P55210 1/20 0.48
CASP6 P55212 1/20 0.48
MCL1 Q07820 1/20 0.48
RIN1 Q13671 1/20 0.48
TDP1 Q9NUW8 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL379725 0.83 KMT2A (0.54) PTPN1NPC1RAB9AKDM4EALDH1A1
SCHEMBL8604333 0.83 HSD17B3 (0.55) HSD17B3PTPN1NPC1RAB9ABLM
SCHEMBL180665 0.82 GSK3B (0.53) NPC1RAB9AALDH1A1POLBCA1
SCHEMBL6656619 0.82 HSD17B3 (0.50) HSD17B3PTPN1NPC1RAB9ABLM
SCHEMBL10594877 0.82 GSK3B (0.53) NPC1RAB9AALDH1A1POLBL3MBTL1
SCHEMBL20159133 0.82 LMNA (0.43) NPC1RAB9ABLMKDM4EPOLB
SCHEMBL1748034 0.78 SMN1; SMN2 (0.44) PTPN1RAB9AKDM4EALDH1A1TDP1
SCHEMBL7441224 0.77 NPC1 (0.47) HSD17B3PTPN1NPC1RAB9ABLM
SCHEMBL1373141 0.77 ESR1 (0.56) HSD17B3PTPN1NPC1RAB9AALDH1A1
SCHEMBL4095875 0.75 ALDH1A1 (0.54) NPC1RAB9AALDH1A1GAAAPEX1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5135940-A Antiallegens, antiinflammatory agents MERCK FROSST CANADA, INC. (CA) 1992-08-04 US disclosed
EP-0252639-A1 Leukotriene antagonists MERCK FROSST CANADA INC. (CA) 1988-01-13 EP disclosed
EP-0104885-B1 LEUKOTRIENE ANTAGONISTS, THEIR PRODUCTION, AND COMPOSITIONS CONTAINING THEM MERCK FROSST CANADA INC. (CA) 1986-06-04 EP disclosed
EP-0104885-A1 Leukotriene antagonists, their production, and compositions containing them MERCK FROSST CANADA INC. (CA) 1984-04-04 EP disclosed